AR038930A1 - Proceso para sintetizar n-arilpiperazinas con sustitucion con n'-1-(benzoil(2-piridil)amino)-2-propano quiral - Google Patents
Proceso para sintetizar n-arilpiperazinas con sustitucion con n'-1-(benzoil(2-piridil)amino)-2-propano quiralInfo
- Publication number
- AR038930A1 AR038930A1 ARP030100831A ARP030100831A AR038930A1 AR 038930 A1 AR038930 A1 AR 038930A1 AR P030100831 A ARP030100831 A AR P030100831A AR P030100831 A ARP030100831 A AR P030100831A AR 038930 A1 AR038930 A1 AR 038930A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- amino
- chiral
- propane
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- -1 AMINO Chemical class 0.000 title abstract 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 title 2
- 239000001294 propane Substances 0.000 title 1
- 230000003407 synthetizing effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 9
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000000010 aprotic solvent Substances 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 125000006371 dihalo methyl group Chemical group 0.000 abstract 1
- 238000006073 displacement reaction Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004970 halomethyl group Chemical group 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 239000003880 polar aprotic solvent Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000007363 ring formation reaction Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 abstract 1
- 125000004953 trihalomethyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Un proceso para la formación de N-arilpiperazinas con cadenas laterales de N'-1-[benzoil(2-piridil)amino]-2-propano que tienen la estructura expuesta en la fórmula (1), donde * indica un centro quiral, y para la preparación de los compuestos intermediarios de las mismas. En este proceso, se introduce la quiralidad en el paso de formación del anillo de piperazina y se incorpora la sustitución con 2-aminopiridilo por medio de desplazamiento. Las piparazinas N,N'-disustituidas así obtenidas actúan sobre el sistema nervioso central como receptores de 5HT. Reivindicación 1: Un proceso para la preparación de un compuesto de la fórmula (2) en la cual: R es alquilo C1-3; Y representa una porción seleccionada entre el grupo que consiste en alcoxi C1-6, alquilo C1-6, cicloalquilo C3-7, cicloalcoxi C3-7; y Ar es 2,3-dihidro-benzodioxin-5-ilo o fenilo optativamente sustituido con hasta tres sustituyentes independientemente seleccionados entre halógeno, metoxi, halometilo, dihalometilo y trihalometilo; proceso que comprende los siguientes pasos: a) la reacción de un compuesto de la fórmula (3) con un 2-amino-1-alcanol(C3-5) quiral en un solvente aprótico polar para formar un compuesto de la fórmula (4) en la cual L representa un grupo saliente seleccionado entre Cl, Br, mesilato, triflato y tosilato y * indica un centro quiral; b) la conversión del compuesto de la fórmula (4) a un compuesto de la fórmula (5) en la cual X es Cl o Br; y c) el tratamiento del compuesto de la fórmula (5) con un compuesto de la fórmula (6) en un solvente aprótico, en la cual M es un metal alcalino, para producir el compuesto de fórmula (2).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36343102P | 2002-03-12 | 2002-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038930A1 true AR038930A1 (es) | 2005-02-02 |
Family
ID=28041762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100831A AR038930A1 (es) | 2002-03-12 | 2003-03-11 | Proceso para sintetizar n-arilpiperazinas con sustitucion con n'-1-(benzoil(2-piridil)amino)-2-propano quiral |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6713626B2 (es) |
| EP (1) | EP1483255B1 (es) |
| JP (1) | JP4391241B2 (es) |
| KR (1) | KR20040105765A (es) |
| CN (2) | CN1982307A (es) |
| AR (1) | AR038930A1 (es) |
| AT (1) | ATE439356T1 (es) |
| AU (1) | AU2003220094B2 (es) |
| BR (1) | BR0308377A (es) |
| CA (1) | CA2477892C (es) |
| CR (1) | CR7431A (es) |
| DE (1) | DE60328756D1 (es) |
| EC (1) | ECSP045290A (es) |
| ES (1) | ES2329122T3 (es) |
| IL (1) | IL163827A0 (es) |
| MX (1) | MXPA04008729A (es) |
| NO (1) | NO20044050L (es) |
| NZ (1) | NZ535168A (es) |
| RU (1) | RU2315762C2 (es) |
| TW (1) | TW200403231A (es) |
| UA (1) | UA79273C2 (es) |
| WO (1) | WO2003078417A1 (es) |
| ZA (1) | ZA200408202B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223824A1 (en) | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
| US20060287335A1 (en) * | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
| JP5080716B2 (ja) | 2001-07-20 | 2012-11-21 | サイコジェニックス・インコーポレーテッド | 注意欠陥・多動性障害の治療 |
| TWI288642B (en) * | 2002-03-12 | 2007-10-21 | Wyeth Corp | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| US7361773B2 (en) | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| US7091349B2 (en) * | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| NZ535169A (en) * | 2002-03-12 | 2006-03-31 | Wyeth Corp | Process for making chiral 1,4-disubstituted piperazines |
| US20050209245A1 (en) * | 2004-03-19 | 2005-09-22 | Wyeth | Process for preparing N-aryl-piperazine derivatives |
| US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| JP2008531694A (ja) * | 2005-03-01 | 2008-08-14 | ワイス | 結晶性および非晶性４−シアノ−ｎ−｛（２ｒ）−２−［４−（２，３−ジヒドロ−ベンゾ［１，４］ジオキシン−５−イル）−ピペラジン−１−イル］−プロピル｝−ｎ−ピリジン−２−イル−ベンズアミド塩酸塩 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE81975T1 (de) | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| JPH01125357A (ja) | 1987-11-06 | 1989-05-17 | Dainippon Pharmaceut Co Ltd | トリペプチドの誘導体 |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| WO1994024115A1 (en) * | 1993-04-16 | 1994-10-27 | Santen Pharmaceutical Co., Ltd. | Novel piperazine derivative |
| GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
| AU2622595A (en) | 1994-06-03 | 1996-01-04 | John Wyeth & Brother Limited | Novel processes and intermediates for the preparation of piperazine derivatives |
| GB9413772D0 (en) * | 1994-07-08 | 1994-08-24 | Wyeth John & Brother Ltd | 5-HT1A ligands |
| GB9514901D0 (en) * | 1995-07-20 | 1995-09-20 | American Home Prod | Piperazine derivatives |
| JP2000508319A (ja) | 1996-04-10 | 2000-07-04 | メルク エンド カンパニー インコーポレーテッド | αｖβ３拮抗薬 |
| US6469007B2 (en) | 2000-11-28 | 2002-10-22 | Wyeth | Serotonergic agents |
-
2003
- 2003-03-10 CN CNA2007100083292A patent/CN1982307A/zh active Pending
- 2003-03-10 AT AT03716384T patent/ATE439356T1/de not_active IP Right Cessation
- 2003-03-10 ES ES03716384T patent/ES2329122T3/es not_active Expired - Lifetime
- 2003-03-10 MX MXPA04008729A patent/MXPA04008729A/es active IP Right Grant
- 2003-03-10 BR BR0308377-2A patent/BR0308377A/pt not_active IP Right Cessation
- 2003-03-10 DE DE60328756T patent/DE60328756D1/de not_active Expired - Lifetime
- 2003-03-10 US US10/384,845 patent/US6713626B2/en not_active Expired - Fee Related
- 2003-03-10 RU RU2004130300/04A patent/RU2315762C2/ru not_active IP Right Cessation
- 2003-03-10 KR KR10-2004-7014156A patent/KR20040105765A/ko not_active Application Discontinuation
- 2003-03-10 WO PCT/US2003/007078 patent/WO2003078417A1/en active Application Filing
- 2003-03-10 IL IL16382703A patent/IL163827A0/xx unknown
- 2003-03-10 CA CA2477892A patent/CA2477892C/en not_active Expired - Fee Related
- 2003-03-10 AU AU2003220094A patent/AU2003220094B2/en not_active Expired - Fee Related
- 2003-03-10 TW TW092105097A patent/TW200403231A/zh unknown
- 2003-03-10 NZ NZ535168A patent/NZ535168A/xx unknown
- 2003-03-10 JP JP2003576423A patent/JP4391241B2/ja not_active Expired - Fee Related
- 2003-03-10 EP EP03716384A patent/EP1483255B1/en not_active Expired - Lifetime
- 2003-03-10 CN CNB038058413A patent/CN1304388C/zh not_active Expired - Fee Related
- 2003-03-11 AR ARP030100831A patent/AR038930A1/es unknown
- 2003-10-03 UA UA20041008211A patent/UA79273C2/uk unknown
-
2004
- 2004-08-24 CR CR7431A patent/CR7431A/es not_active Application Discontinuation
- 2004-09-10 EC EC2004005290A patent/ECSP045290A/es unknown
- 2004-09-24 NO NO20044050A patent/NO20044050L/no not_active Application Discontinuation
- 2004-10-11 ZA ZA200408202A patent/ZA200408202B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4391241B2 (ja) | 2009-12-24 |
| WO2003078417A1 (en) | 2003-09-25 |
| JP2005526775A (ja) | 2005-09-08 |
| US6713626B2 (en) | 2004-03-30 |
| ZA200408202B (en) | 2007-03-28 |
| KR20040105765A (ko) | 2004-12-16 |
| CN1982307A (zh) | 2007-06-20 |
| CN1304388C (zh) | 2007-03-14 |
| CA2477892C (en) | 2010-11-23 |
| AU2003220094B2 (en) | 2009-04-23 |
| RU2315762C2 (ru) | 2008-01-27 |
| RU2004130300A (ru) | 2005-04-10 |
| EP1483255A1 (en) | 2004-12-08 |
| US20030187265A1 (en) | 2003-10-02 |
| MXPA04008729A (es) | 2005-07-13 |
| IL163827A0 (en) | 2005-12-18 |
| EP1483255B1 (en) | 2009-08-12 |
| ATE439356T1 (de) | 2009-08-15 |
| UA79273C2 (en) | 2007-06-11 |
| ECSP045290A (es) | 2004-10-26 |
| TW200403231A (en) | 2004-03-01 |
| NZ535168A (en) | 2006-03-31 |
| AU2003220094A1 (en) | 2003-09-29 |
| DE60328756D1 (de) | 2009-09-24 |
| BR0308377A (pt) | 2005-01-11 |
| CN1642936A (zh) | 2005-07-20 |
| CA2477892A1 (en) | 2003-09-25 |
| NO20044050L (no) | 2004-09-24 |
| ES2329122T3 (es) | 2009-11-23 |
| CR7431A (es) | 2008-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038930A1 (es) | Proceso para sintetizar n-arilpiperazinas con sustitucion con n'-1-(benzoil(2-piridil)amino)-2-propano quiral | |
| AR075255A1 (es) | Derivados diazolicos y/o triazolicos agonistas de receptores tgr5 acoplado a proteina g, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de la obesidad, diabetes y otros trastornos metabolicos. | |
| PE20061298A1 (es) | Compuestos derivados de dihidrobenzofurano como agonistas del receptor de serotonina 5-ht2c | |
| AR057433A1 (es) | Compuestos quimicos derivados de piridopirimidina, un metodo para su preparacion y composicion farmaceutica | |
| AR067346A1 (es) | Derivados de bencimidazol | |
| NO331165B1 (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter | |
| AR081333A1 (es) | Metodo para preparar derivados de cicloalquilcarboxamidoindol, en particular (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-il)-n-(1-(2,3-dihidroxipropil)-6-fluoro-2-(1-hidroxi-2-metilpropan-2-il)-1h-indol-5-il)ciclopropancarboxamida, compuestos intermediarios de dicha sintesis y metodo para prepararlos. | |
| CY1109015T1 (el) | Διφαινυλ ενωσεις χρησιμες ως ανταγωνιστες μουσκαρινικου υποδοχεα | |
| AR058719A1 (es) | Derivados de isoxazol-4-il-oxadiazol | |
| AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
| RS53059B (en) | NEW SUBSTITUTED IMIDAZOCHINOLINES | |
| EA201170096A1 (ru) | Замещенные производные пиримидона | |
| UY31388A1 (es) | Método para la producción de 2´-desoxi-5-azacitidina (decitabina) | |
| PE20061144A1 (es) | DERIVADOS DE PIRROLIDINA Y PIPERIDINA ACETILENO COMO ANTAGONISTAS DE LOS RECEPTORES DE GLUTAMATO METABOTROPICO (mGluRs) | |
| PE20090189A1 (es) | Derivados de aza-piridopirimidinona como agonistas de hm74a | |
| UY27853A1 (es) | Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
| UY32180A (es) | Antagonistas del receptor transitorio potencial de vanilloides 1 (trpv1) | |
| CL2012000516A1 (es) | Compuestos derivados de 3-[4-(4-(fenil/piridin/ pirimidin)- piperazin -1-il)-butil]-2, 3-dihidro-4h-croman-4-ona, moduladores del receptor de dopamina d3; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de un desorden neurologico o psiquiatrico, disfuncion erectil o dependencia a drogas, entre otros. | |
| AR021354A1 (es) | Procedimiento para la preparacion de un compuesto derivado de quinolina y un procedimiento para preparar una composicion farmaceutica | |
| AR072225A1 (es) | Derivados de alquil pirimidin-4-ona sustituidos y procedimiento para prepararlos | |
| AR067869A1 (es) | Derivados de piridina y pirimidina | |
| PE20140968A1 (es) | Derivados de benzamida sustituida | |
| AR064136A1 (es) | Derivados de espiro-piperidina, metodos para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades relacionadas con la accion antagonista del receptor v1a. | |
| AR053410A1 (es) | Proceso para la sintesis de indoles n-alquilados c-2, c-3 sustituidos. compuestos intermediarios | |
| CO5660263A2 (es) | Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |